HER2 Overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

✍ Scribed by J. McAlpine; K. Wiegand; M. Miller; A. Adamiak; M. Koebel; R. Vang; B. Ronnett; K. Swenerton; D. Huntsman; C. Gilks; D. Miller

• Book ID: 113962255
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 99 KB
• Volume: 116
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2009.10.004